Fibrate-Associated Adverse Effects Beyond Muscle and Liver Toxicity

Author(s): M. S. Elisaf, M. Florentin, E. N. Liberopoulos, D. P. Mikhailidis

Journal Name: Current Pharmaceutical Design

Volume 14 , Issue 6 , 2008

Become EABM
Become Reviewer


Fibrate derivatives have a 40-year history in the management of dyslipidemia. Although this class of drugs is generally well tolerated, several safety issues have arisen from their use. In the present article we review the literature describing side effects associated with the use of fibrates except for those that are liver and muscle related. These effects are less well known but are clinically relevant.

Keywords: Fibrates, Fibric acid derivatives, Peroxisome proliferator-activated receptors (PPAR), Side effects, Adverse effects, Renal effects, Thrombosis, Gallbladder disease

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Page: [574 - 587]
Pages: 14
DOI: 10.2174/138161208783885362
Price: $65

Article Metrics

PDF: 10